These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 25984669)
1. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus. Lin J; Li N; Chen H; Liu C; Yang B; Ou Q Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669 [TBL] [Abstract][Full Text] [Related]
2. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study. Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124 [TBL] [Abstract][Full Text] [Related]
3. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE. Tripathy R; Panda AK; Das BK Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568 [TBL] [Abstract][Full Text] [Related]
4. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus. Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890 [TBL] [Abstract][Full Text] [Related]
6. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus. Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774 [TBL] [Abstract][Full Text] [Related]
7. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA; El-Gendi HI; Ahmed HH Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928 [TBL] [Abstract][Full Text] [Related]
9. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis. Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596 [TBL] [Abstract][Full Text] [Related]
10. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity. El-Banna HS; El Khouly RM; Gado SE Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692 [TBL] [Abstract][Full Text] [Related]
11. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus. Li H; Meng D; Jia J; Wei H Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924 [TBL] [Abstract][Full Text] [Related]
12. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases]. Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Wang H; Li T; Chen S; Gu Y; Ye S Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802 [TBL] [Abstract][Full Text] [Related]
14. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus]. Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195 [No Abstract] [Full Text] [Related]
15. [Diagnostic significance of anti-collectin 11 in systemic lupus erythematosus]. Deng XL; Zhong LJ; Sun L; Li CH; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):982-986. PubMed ID: 27987501 [TBL] [Abstract][Full Text] [Related]
16. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension. Fan Y; Zhao J; Qian J; Hao Y; Wang Q; Gao L; Li M; Zeng X; Zhang Z Clin Exp Rheumatol; 2019; 37(4):623-632. PubMed ID: 30620287 [TBL] [Abstract][Full Text] [Related]
18. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582 [TBL] [Abstract][Full Text] [Related]
19. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus. Hafez EA; Hassan SAE; Teama MAM; Badr FM Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012 [TBL] [Abstract][Full Text] [Related]
20. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus. Wu Q; Yang Q; Sun H Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]